(Q34807471)

4 August 2017

1 reference

title

Infections and solid organ transplant rejection: a cause-and-effect relationship? (English)

1 reference

4 August 2017

Francesca Cainelli

1

0 references

Sandro Vento

object named as

Sandro Vento

series ordinal

2

0 references

publication date

1 September 2002

1 reference

Lancet Infectious Diseases

4 August 2017

1 reference

4 August 2017

2

1 reference

4 August 2017

9

1 reference

4 August 2017

539-549

1 reference

Viral syndromes and renal homograft rejection.

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Association of renal allograft rejection with virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Virus Infections and Acute Renal Transplant Rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Association between Streptococcus faecalis urinary infections and graft rejection in kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Risk factors for chronic rejection in renal allograft recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Late urinary-tract infection after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Urinary tract infections after renal transplantation: do they matter?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Late urinary tract infection after transplantation: prevalence, predisposition and morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Cytomegalovirus and human herpesvirus 6 both cause viral disease after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

CMV infection, class II antigen expression, and human kidney allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Demonstration by light microscopy of cytomegalovirus on a renal biopsy of a renal allograft recipient: confirmation by immunohistochemistry and in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Cytomegalovirus infection--an etiological factor for rejection? A prospective study in 242 renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Cytomegalovirus prophylaxis with antiviral agents in solid organ transplantation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Immunologic parameters as predictive factors of cytomegalovirus disease in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Potential involvement of IL-8 in the pathogenesis of human cytomegalovirus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Glomerulopathy Associated with Cytomegalovirus Viremia in Renal Allografts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Association of Herpesvirus Infections with T-Lymphocyte-Subset Alterations, Glomerulopathy, and Opportunistic Infections after Renal Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Cytomegalovirus glomerulopathy: a controversial lesion

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

The clinical significance of cytomegalovirus infection in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Serological responses to cytomegalovirus during renal transplant rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Bronchiolitis obliterans in recipients of single, double, and heart-lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

HUMAN CYTOMEGALOVIRUS EARLY INFECTION, ACUTE REJECTION, AND MAJOR HISTOCOMPATIBILITY CLASS II EXPRESSION IN TRANSPLANTED LUNG

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

THE INFLUENCE OF CYTOMEGALOVIRUS VIRAEMIA ON THE OUTCOME OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION12

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Risk factors for chronic rejection--a clinical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Cytomegalovirus infections following renal transplantation--effects on antiviral prophylaxis: a report of the North American Pediatric Renal Transplant Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Cytomegalovirus as a risk factor in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Cytomegalovirus disease recurrence after ganciclovir treatment in kidney and kidney-pancreas transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Elevated factor VIII as a marker for vascular type of rejection after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Tumour necrosis factor alpha stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Acute rejection before cytomegalovirus infection enhances von Willebrand factor and soluble VCAM-1 in blood

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Adhesion molecules and rejection of renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

CMV as an exacerbating agent in transplant vascular sclerosis: potential immune-mediated mechanisms modelled in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Cytomegalovirus infection induces vascular injury in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of "angiographically silent" intimal thickening

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Correlation of donor characteristics with transplant coronary artery disease as assessed by intracoronary ultrasound and coronary angiography

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Risk factors for development of accelerated coronary artery disease in cardiac transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Cytomegalovirus nucleic acids in allografted hearts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Cytomegalovirus infection accelerates cardiac allograft vasculopathy: correlation between angiographic and endomyocardial biopsy findings in heart transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Cytomegalovirus infection and allospecific cytotoxic activity of graft-infiltrating cells after heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Risk factor analysis for the major hazards following heart transplantation--rejection, infection, and coronary occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Combined human cytomegalovirus and hepatitis C virus infections increase the risk of allograft vascular disease in heart transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Enhancement of cytomegalovirus infection and acute rejection after allogeneic lung transplantation in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Cytomegalovirus infection and pneumonitis. Impact after isolated lung transplantation. Washington University Lung Transplant Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Cytomegalovirus infection is associated with increased inflammation and severe bile duct damage in rat liver allografts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

An association between cytomegalovirus infection and chronic rejection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Recipient HLA-DR3, tumour necrosis factor-α promoter allele-2 (tumour necrosis factor-2) and cytomegalovirus infection are inter-related risk factors for chronic rejection of liver grafts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Predictive factors for portal fibrosis in pediatric liver transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Lack of association between cytomegalovirus infection, HLA matching and the vanishing bile duct syndrome after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Effect of partial HLA class I match on acute rejection in viral pre-infected human liver allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

In Vitro Suppression of Bone Marrow Progenitor Cell Differentiation by Human Herpesvirus 6 Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Longitudinal study of human herpesvirus 6 infection in organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Association of human herpesvirus 6 reactivation with severe cytomegalovirus-associated disease in orthotopic liver transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Human herpesvirus-6 infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Human herpesvirus-6 antigenemia after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Effects of Interferon-Alpha on Cytomegalovirus Reactivation Syndromes in Renal-Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Recombinant leucocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Abstension from treatment of low-level pp65 cytomegalovirus antigenemia after liver transplantation: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Preemptive use of oral ganciclovir to prevent cytomegalovirus infection in liver transplant patients: a randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

CYTOMEGALOVIRUS ANTIGENEMIA DIRECTED PRE-EMPTIVE PROPHYLAXIS WITH ORAL VERSUS I.V. GANCICLOVIR FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE IN LIVER TRANSPLANT RECIPIENTS1

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal Allografts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Cytomegalovirus induced up-regulation of LFA-3 (CD58) and ICAM-1 (CD54) is a direct viral effect that is not prevented by ganciclovir or foscarnet treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Human cytomegalovirus late protein encoded by ie2: a trans-activator as well as a repressor of gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28−/− mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900370-5

7 January 2021

10.1016/S1473-3099(02)00370-5

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12206970